Biggest News Aggregation in the World
📰 Imux News

Imux News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Imux. Real-time updates on events, politics, business and more.

Immunic (NASDAQ:IMUX) Downgraded to Sell at StockNews.com

StockNews.com cut shares of Immunic (NASDAQ:IMUX – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. Separately, Brookline Capital Management reaffirmed a buy rating and set a $10.00 target price on shares of Immunic in a research report on Friday, April 5th. View Our Latest Report […]
United States Immunic Inc Innovis Asset Management Sweet Financial Partners Acadian Asset Management Sierra Summit Advisors
Source: wkrb13.com

Immunic (IMUX) to Release Earnings on Thursday

Immunic (NASDAQ:IMUX – Get Free Report) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Immunic (NASDAQ:IMUX – Get Free Report) last released its earnings results on Tuesday, November 14th. The company reported ($0.51) EPS for […]
United States Jpmorgan Chase Co American Century Companies Inc Sigma Securities Immunic Inc Charles Schwab Investment Management Inc

Leerink Partnrs Comments on Immunic, Inc.'s FY2028 Earnings (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX – Free Report) – Analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Immunic in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.66) per share for the year. The consensus estimate […]
Leerink Partnrs Vontobel Holding Ltd Gratus Capital Innovis Asset Management Immunic Inc Acadian Asset Management

Immunic (NASDAQ:IMUX) PT Raised to $7.00 at Wedbush

Immunic (NASDAQ:IMUX – Free Report) had its price target lifted by Wedbush from $5.00 to $7.00 in a research note published on Tuesday, MarketBeat Ratings reports. The firm currently has an outperform rating on the stock. Separately, StockNews.com initiated coverage on Immunic in a research note on Thursday, October 5th. They issued a sell rating […]
Sigma Securities Schonfeld Strategic Advisors Immunic Inc Immunic Company Profile Wolverine Trading Blackrock Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Immunic (NASDAQ:IMUX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note issued to investors on Thursday. The firm issued a sell rating on the stock. Separately, Wedbush reaffirmed an outperform rating and set a $5.00 price target on shares of Immunic in a research report on Friday, August 4th. View Our […]
Vivo Capital Artal Group Acadian Asset Management Immunic Inc Morgan Stanley Free Report

Innovis Asset Management LLC Purchases Shares of 80,773 Immunic, Inc. (NASDAQ:IMUX)

Innovis Asset Management LLC purchased a new stake in Immunic, Inc. (NASDAQ:IMUX – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 80,773 shares of the company’s stock, valued at approximately $120,000. Innovis Asset Management LLC owned 0.18% […]
United States Vivo Capital Immunic Company Profile Innovis Asset Management America Corp Exchange Commission

Immunic (NASDAQ:IMUX) Rating Reiterated by Wedbush

Wedbush restated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com started coverage on Immunic in a research note on Thursday, May 18th. They issued a sell rating on the stock. […]
Virtu Financial Innovis Asset Management Vontobel Holding Ltd Artal Group Gratus Capital Immunic Inc
Source: wkrb13.com

Immunic (NASDAQ:IMUX) Receives Outperform Rating from Wedbush

Wedbush reaffirmed their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note published on Friday morning, RTT News reports. They currently have a $5.00 price target on the stock. Separately, StockNews.com initiated coverage on Immunic in a research report on Thursday, May 18th. They set a sell rating on the […]
Vontobel Holding Ltd Immunic Inc Immunic Company Profile Charles Schwab Investment Management Inc Jpmorgan Chase Co Marshall Wace

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush

Wedbush reiterated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. Separately, StockNews.com began coverage on Immunic in a research report on Thursday, May 18th. They issued a sell rating on the stock. One […]
Jpmorgan Chase Co Metlife Investment Management Vontobel Holding Ltd Marshall Wace Immunic Inc Free Report

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science